tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Carlsmed raises FY25 revenue view to $49M-$50M from $45.5M-$47.5M

Consensus $46.52M. The company said, “Revenue for the full year 2025 is expected to be in the range of $49.0 to $50.0 million, representing growth of 80% to 84% over 2024. This compares to prior guidance of $45.5 to $47.5 million.”

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1